Doximity (DOCS) Registers a Bigger Fall Than the Market: Important Facts to Note

Doximity stock fell 2.2% on September 15, 2026, outpacing the broader market decline. The medical social networking company is expected to report a 24.44% EPS decline for the upcoming quarter, though revenue is projected to grow 1.27% year-over-year. The stock holds a Zacks Rank #3 (Hold) rating with a Forward P/E of 19.78, trading at a discount to its industry average.